AMIVAS

Serial Number 98206701
Registration 7502051
700

Registration Progress

Application Filed
Oct 2, 2023
Under Examination
Approved for Publication
Jun 25, 2024
Published for Opposition
Jun 25, 2024
Registered
Sep 10, 2024

Trademark Image

AMIVAS

Basic Information

Serial Number
98206701
Registration Number
7502051
Filing Date
October 2, 2023
Registration Date
September 10, 2024
Published for Opposition
June 25, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 10, 2024
Registration
Registered
Classes
005

Rights Holder

Amivas Inc.

03
Address
100 Tuscanney Drive, Suite B2
Frederick, MD 21702

Ownership History

Amivas Inc.

Original Applicant
03
Frederick, MD

Amivas Inc.

Owner at Publication
03
Frederick, MD

Amivas Inc.

Original Registrant
03
Frederick, MD

Legal Representation

Attorney
Laura K. Pitts

USPTO Deadlines

Next Deadline
1866 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-10)
Due Date
September 10, 2030
Grace Period Ends
March 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Sep 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 25, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 25, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 5, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of malaria; Injectable pharmaceuticals for the treatment of infectious diseases; Injectable pharmaceuticals for the treatment of malaria
First Use Anywhere: Mar 30, 2021
First Use in Commerce: Mar 30, 2021

Additional Information

Design Mark
The mark consists of the word AMIVAS in stylized letters to the left of a design comprised of four columns of stacked squares with the first column having four squares, the second having three squares, the third having two squares and the fourth having one square.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005